Euclidean Capital as of March 31, 2022
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | 28.3 | $49M | 2.3M | 20.82 | |
| 23andme Holding Class A Com (ME) | 22.8 | $39M | 10M | 3.83 | |
| Foghorn Therapeutics (FHTX) | 11.2 | $19M | 1.3M | 15.23 | |
| Alector (ALEC) | 8.1 | $14M | 981k | 14.25 | |
| Ngm Biopharmaceuticals | 6.6 | $11M | 747k | 15.25 | |
| Tenaya Therapeutics (TNYA) | 6.3 | $11M | 916k | 11.78 | |
| Rapt Therapeutics (RAPT) | 5.5 | $9.5M | 433k | 21.99 | |
| Coinbase Global Com Cl A (COIN) | 5.2 | $8.9M | 47k | 189.87 | |
| First Financial Ban (FFBC) | 2.3 | $4.0M | 174k | 23.05 | |
| Oric Pharmaceuticals (ORIC) | 2.3 | $4.0M | 748k | 5.34 | |
| Surrozen | 1.4 | $2.4M | 803k | 3.01 |
